Phase 2 Clinical Trial of CartiLife® in the United States
Phase 2 Clinical Trial of CartiLife® in the United States
Recruiting · NCT04744402 · Registry updated 2023-08-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 2 Clinical Trial of CartiLife® in the United States | Articular Cartilage Defect; Articular Cartilage Degeneration | Recruiting | Phase 2 | 2023-08-28 | NCT04744402 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Biosolution Co., Ltd. | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Biosolutions Clinical Research Center | La Mesa | United States | 7 |
| Horizon Clinical Research | La Mesa | United States | 9 |
| Lafayette General Health | Lafayette | United States | 1 |
| Ohio State University | Columbus | United States | 169 |
| Tilda Research | Irvine | United States | 1 |